Lucilla Fabbri
Overview
Explore the profile of Lucilla Fabbri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Truffinet F, Arco-Hierves A, Shalabi H, Pascaud J, Mazet P, Riviere E, et al.
Ann Rheum Dis
. 2024 Sep;
PMID: 39299724
Objectives: The RNA epitranscriptomic modification known as -methyladenosine (mA) represents a novel mechanism of gene regulation that is poorly understood in human autoimmune diseases. Our research explores the role of...
2.
Bonnet C, Dian A, Espie-Caullet T, Fabbri L, Lagadec L, Pivron T, et al.
Bull Cancer
. 2024 Jun;
111(7-8):782-790.
PMID: 38824069
A better understanding of the RNA biology and chemistry is necessary to then develop new RNA therapeutic strategies. This review is the synthesis of a series of conferences that took...
3.
Aube F, Fontrodona N, Guiguettaz L, Vallin E, Fabbri L, Lapendry A, et al.
NAR Cancer
. 2024 May;
6(2):zcae019.
PMID: 38690580
Amino acid bioavailability impacts mRNA translation in a codon-dependent manner. Here, we report that the anti-cancer MAPK inhibitors (MAPKi) decrease the intracellular concentration of aspartate and glutamate in melanoma cells....
4.
Fabbri L, Chakraborty A, Robert C, Vagner S
Nat Rev Cancer
. 2021 Aug;
21(9):558-577.
PMID: 34341537
Translational control of mRNAs during gene expression allows cells to promptly and dynamically adapt to a variety of stimuli, including in neoplasia in response to aberrant oncogenic signalling (for example,...
5.
Sadaghianloo N, Contenti J, Declemy S, Ambrosetti D, Zdralevic M, Tannour-Louet M, et al.
J Physiol
. 2021 Feb;
599(8):2299-2321.
PMID: 33608879
Key Points: Patients with end-stage renal failure need arteriovenous fistulas (AVF) to undergo dialysis. However, AVFs present a high rate of failure as a result of excessive venous thickness. Excessive...
6.
Meyenberg Cunha-de Padua M, Fabbri L, Dufies M, Lacas-Gervais S, Contenti J, Voyton C, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33238609
Metabolic flexibility is the ability of a cell to adapt its metabolism to changes in its surrounding environment. Such adaptability, combined with apoptosis resistance provides cancer cells with a survival...
7.
Fabbri L, Dufies M, Lacas-Gervais S, Gardie B, Gad-Lapiteau S, Parola J, et al.
Theranostics
. 2020 Mar;
10(6):2696-2713.
PMID: 32194829
: Renal cell carcinoma (RCC) accounts for about 2% of all adult cancers, and clear cell RCC (ccRCC) is the most common RCC histologic subtype. A hallmark of ccRCC is...
8.
Sadaghianloo N, Contenti J, Dufies M, Parola J, Rouleau M, Lee S, et al.
J Cell Mol Med
. 2020 Feb;
24(5):2931-2941.
PMID: 32032472
Arteriovenous fistulas (AVFs) are the preferred vascular access for haemodialysis of patients suffering from end-stage renal disease, a worldwide public health problem. However, they are prone to a high rate...
9.
Fabbri L, Bost F, Mazure N
Int J Mol Sci
. 2019 Mar;
20(6).
PMID: 30884815
The primary cilium is a solitary, nonmotile and transitory appendage that is present in virtually all mammalian cells. Our knowledge of its ultrastructure and function is the result of more...
10.
Ferecatu I, Canal F, Fabbri L, Mazure N, Bouton C, Golinelli-Cohen M
PLoS One
. 2018 Mar;
13(3):e0194782.
PMID: 29596470
Biogenesis of iron-sulfur clusters (ISC) is essential to almost all forms of life and involves complex protein machineries. This process is initiated within the mitochondrial matrix by the ISC assembly...